Hospital BP

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Bladder cancer1 trial
• Chronic lymphocytic leukaemia1 trial

Phase

• Phase 34 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Loxo Oncology, Inc.1 trial

Running trials

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Eli Lilly and Company· Source

  Contact: Fabio Schutz (principal investigator)

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Eli Lilly and Company· Source

  Contact: Marcelo Corassa (principal investigator)

• Recruiting

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT05254743· Phase 3· Loxo Oncology, Inc.· Source

  Contact: Danielle Leão Cordeiro de Farias (principal investigator)

• Active, not recruiting

  A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT04819100· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Lung cancer1 recruiting